How new nicotine products and industry actions affect smoking and health
An Economic and Public Health Analysis of the Evolving Nicotine Marketplace
This project looks at how e-cigarettes, heated tobacco, and company actions may change smoking habits and health risks for adults and young people across several countries.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11189000 on NIH RePORTER |
What this research studies
From my perspective as someone affected by tobacco, the researchers are building economic and simulation models to predict how sales, marketing, and pricing of cigarettes, e-cigarettes (NVPs), and heated tobacco products (HTPs) affect use and health. They will model how traditional cigarette companies and newer firms might react to tobacco control policies. The team will expand the framework to include multiple nicotine products and run country-specific simulations for seven countries with different regulations and use patterns. The analyses combine market data, public health data, and policy scenarios to estimate long-term impacts on smoking, vaping, and related disease.
Who could benefit from this research
Good fit: People who smoke, vape, use heated tobacco products, or are at risk of starting (including young adults) in the countries modeled would be most relevant.
Not a fit: People in countries not covered by the seven-country models or those with no exposure to nicotine products may not see direct benefits.
Why it matters
Potential benefit: If successful, the work could inform policies that reduce smoking and vaping harms and help prevent youth uptake.
How similar studies have performed: Previous economic and simulation studies have informed tobacco policy, but applying these methods to newer products like e-cigarettes and HTPs is more recent and less certain.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Levy, David Theodore — Medical University of South Carolina
- Study coordinator: Levy, David Theodore
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.